AstraZeneca to invest £11bn in China after rowing back on UK expansion

Move comes after Britain’s biggest drugmaker’s dispute with government over drug pricingBritain’s biggest drugmaker AstraZeneca is to invest $15bn (£11bn) in China, it announced during Keir Starmer’s visit to the country, just months after cooling on plans for expansion in the UK.The Cambridge-based company said it would spend the money by 2030 to expand medicines manufacturing and research and development in China, where it already has a big presence. It includes the construction of a $2.5bn new research hub in Beijing, which was announced last March. Continue reading...